Lataa...
Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and STK11: A case report
RATIONALE: Patients reporting high PD-L1 expression have shown to respond well to immunotherapy; however, some patients develop hyperprogressive disease upon initiation of immune checkpoint inhibitors. We report a patient with lung cancer and 100% PD-L1 expression who developed hyperprogressive dise...
Tallennettuna:
| Julkaisussa: | Medicine (Baltimore) |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Lippincott Williams & Wilkins
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7668523/ https://ncbi.nlm.nih.gov/pubmed/33181636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000022323 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|